Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of 5% CSPS Toothpaste for Dentin Hypersensitivity
NCT06378008Completed
- Sponsor
- Haleon
- Start
- Apr 2024
- Primary completion
- Sep 2024
- Modality
- Nanoparticles, Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
Randomised, single-blind trial of calcium sodium phosphosilicate in dentin hypersensitivity (DH) (2 arms), sponsored by Haleon. Primary endpoint: Adjusted Mean Change From Baseline in Schiff Sensitivity Score at Day 56. Started Apr 2024; status: completed.
02
Drugs
calcium sodium phosphosilicate
03
Conditions
dentin hypersensitivity (DH)
Beyond the preview
Go deeper on NCT06378008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06378008.